Entera Bio Ltd.
ENTX
$2.06
-$0.16-7.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.20M | -2.66M | -2.57M | -2.36M | -3.02M |
| Total Depreciation and Amortization | 8.00K | 7.00K | 8.00K | 11.00K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 901.00K | 531.00K | 600.00K | 585.00K | 932.00K |
| Change in Net Operating Assets | -211.00K | 487.00K | 555.00K | 295.00K | -76.00K |
| Cash from Operations | -2.50M | -1.63M | -1.40M | -1.47M | -2.15M |
| Capital Expenditure | -43.00K | -29.00K | -8.00K | -3.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.00K | -29.00K | -8.00K | -3.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 251.00K | 24.00K | 13.52M | 3.54M | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -75.00K | -186.00K | -323.00K | 0.00 |
| Cash from Financing | 250.00K | -51.00K | 13.34M | 3.22M | 13.00K |
| Foreign Exchange rate Adjustments | 29.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.27M | -1.71M | 11.93M | 1.75M | -2.14M |